Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
45.29
+0.35 (0.78%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $2.04 billion as of July 10, 2026. Its market cap has increased by 209.80% in one year.
Market Cap
2.04B
Enterprise Value
1.76B
1-Year Change
209.80%
Ranking
Category
Stock Price
$45.29
Market Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has increased from $733.61M to $2.04B, an increase of 178.74%. That is a compound annual growth rate of 105.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.04B | 11.20% |
| Dec 31, 2025 | 1.84B | 150.27% |
| Feb 7, 2025 | 733.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 2.10B |
| Syndax Pharmaceuticals | 2.09B |
| AbCellera Biologics | 2.08B |
| Palvella Therapeutics | 2.08B |
| Nanobiotix | 2.06B |
| Aurinia Pharmaceuticals | 2.03B |
| Taysha Gene Therapies | 2.03B |
| Nuvation Bio | 2.02B |